Cardio Protection of GLP-1 RAs Agonists GLP-1 RAs, including semaglutide and liraglutide, have shown cardiovascular benefits in patients with type 2 diabetes [34], and emerging evidence suggests tirzepatidea dual GLP-1/GIP agonistmay offer even greater cardio protection, including among cancer patients [35]
By activating both GLP-1 and GIP, tirzepatide can reduce hunger, keep you feeling full longer, and support better blood sugar balance
Do BioHack London publish Certificates of Analysis for both
To explore a detailed, user-friendly resource that illustrates these principles in action, visit and examine how navigation design, promotional clarity, and mobile parity come together to create a smoother journey from sign-up to seasoned play